6:54 PM
 | 
May 09, 2014
 |  BC Extra  |  Company News

Teva sues FDA over Copaxone Citizen's Petition

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) sued FDA in the U.S. District Court for the District of Columbia alleging that the agency's denial "without comment" of a December Citizen's Petition about multiple sclerosis drug Copaxone glatiramer acetate violates the Food, Drug & Cosmetic Act (FDCA).

The December 2013 Citizen's Petition, Teva's sixth for Copaxone, asked FDA to...

Read the full 274 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >